Towards a minimal core dataset for systemic lupus erythematosus studies

Stephen McDonald^{1

2}, Jialin Teng^{1

3}, Chengde Yang⁴, Michelle Barraclough⁵, Graciela S Alarcon^{6

7}, Anca D Askanase⁸, Sasha Bernatsky⁹, Ann Elaine Clarke¹⁰, Nathalie Costedoat-Chalumeau¹¹, Qiang Fu¹², Dafna D Gladman^{13

14}, John G Hanly¹⁵, Alexandra C Legge¹⁵, David Isenberg¹⁶, Kenneth Kalunian¹⁷, Diane L Kamen¹⁸, Michelle A Petri¹⁹, Anisur Rahman¹⁶, Chuanyin Sun²⁰, Ting Li²¹, Murray Urowitz^{22

23}, Alexandre Voskuyl²⁴, Daniel J Wallace²⁵, Juan Zhang²⁶, Ian N Bruce^{27

28}

Affiliations

¹ NIHR Manchester Biomedical Research Centre, Manchester Foundation Trust, Manchester Royal Infirmary Kellgren Centre for Rheumatology, Manchester, UK.
² Rheumatology, HSC Western Health and Social Care Trust, Londonderry, UK.
³ School of Medicine, Department of Rheumatology and Immunology, Shanghai Jiao Tong University, Shanghai, China.
⁴ Rheumatology and Immunology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China.
⁵ Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
⁶ Marnix E Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
⁷ Universidad Peruana Cayetano Heredia, Lima District, Peru.
⁸ Division of Rheumatology, Columbia University Irving Medical Center, New York City, New York, USA.
⁹ Division of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
¹⁰ Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
¹¹ Service de Médecine Interne, Centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares d'Ile-de-France, de l'Est et de l'Ouest, Hopital Cochin, Paris, France.
¹² The First Affiliated Hospital of Nanchang Medical College, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, China.
¹³ Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
¹⁴ Schroeder Arthritis Institute, Krembil Research Institute, Toronto, Ontario, Canada.
¹⁵ Division of Rheumatology, Department of Medicine, Queen Elizabeth II Science Centre & Dalhousie Univeristy, Halifax, Nova Scotia, Canada.
¹⁶ Centre for Rheumatology, University College London, London, UK.
¹⁷ San Diego School of Medicine, Division of Rheumatology, Autoimmunity and Inflammation, University of California San Diego, La Jolla, California, USA.
¹⁸ Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
¹⁹ Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
²⁰ Department of Rheumatology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
²¹ Department of Rheumatology, South Campus, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
²² Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
²³ Schroeder Arthritis Institute, Toronto Western Hospital, Toronto, Ontario, Canada.
²⁴ Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.
²⁵ Rheumatology, Cedars-Sinai Medical Center, West Hollywood, California, USA.
²⁶ Department of Rheumatology, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
²⁷ Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK ian.bruce@manchester.ac.uk.
²⁸ Faculty of Medicine, Health and Life Sciences, Queen's University Belfast, Belfast, UK.

PMID: 40987485
PMCID: PMC12458853
DOI: 10.1136/lupus-2025-001595

Towards a minimal core dataset for systemic lupus erythematosus studies

Stephen McDonald et al. Lupus Sci Med. 2025.

. 2025 Sep 22;12(2):e001595.

doi: 10.1136/lupus-2025-001595.

Authors

Affiliations

¹ NIHR Manchester Biomedical Research Centre, Manchester Foundation Trust, Manchester Royal Infirmary Kellgren Centre for Rheumatology, Manchester, UK.
² Rheumatology, HSC Western Health and Social Care Trust, Londonderry, UK.
³ School of Medicine, Department of Rheumatology and Immunology, Shanghai Jiao Tong University, Shanghai, China.
⁴ Rheumatology and Immunology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China.
⁵ Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
⁶ Marnix E Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
⁷ Universidad Peruana Cayetano Heredia, Lima District, Peru.
⁸ Division of Rheumatology, Columbia University Irving Medical Center, New York City, New York, USA.
⁹ Division of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
¹⁰ Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
¹¹ Service de Médecine Interne, Centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares d'Ile-de-France, de l'Est et de l'Ouest, Hopital Cochin, Paris, France.
¹² The First Affiliated Hospital of Nanchang Medical College, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, China.
¹³ Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
¹⁴ Schroeder Arthritis Institute, Krembil Research Institute, Toronto, Ontario, Canada.
¹⁵ Division of Rheumatology, Department of Medicine, Queen Elizabeth II Science Centre & Dalhousie Univeristy, Halifax, Nova Scotia, Canada.
¹⁶ Centre for Rheumatology, University College London, London, UK.
¹⁷ San Diego School of Medicine, Division of Rheumatology, Autoimmunity and Inflammation, University of California San Diego, La Jolla, California, USA.
¹⁸ Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
¹⁹ Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
²⁰ Department of Rheumatology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
²¹ Department of Rheumatology, South Campus, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
²² Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
²³ Schroeder Arthritis Institute, Toronto Western Hospital, Toronto, Ontario, Canada.
²⁴ Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.
²⁵ Rheumatology, Cedars-Sinai Medical Center, West Hollywood, California, USA.
²⁶ Department of Rheumatology, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
²⁷ Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK ian.bruce@manchester.ac.uk.
²⁸ Faculty of Medicine, Health and Life Sciences, Queen's University Belfast, Belfast, UK.

PMID: 40987485
PMCID: PMC12458853
DOI: 10.1136/lupus-2025-001595

Abstract

Objective: SLE is a complex, heterogenous autoimmune disease. SLE researchers do not always collect the same data, making comparative studies difficult. We aimed to ascertain what variables SLE clinical researchers commonly collect for SLE research. Our ultimate goal is to generate a minimal core dataset for future SLE studies.

Methods: In 2020, we designed and distributed a questionnaire to members of the Systemic Lupus Erythematosus International Collaborating Clinics (SLICC) as well as additional active research centres in China. Our survey included 26 questions about the types of data that are routinely collected for research. Variables collected by ≥75% of participating respondents were used as a threshold for inclusion.

Results: 18 of 36 invited respondents replied (8 from USA/Canada, 5 from China and 5 from Europe). Many key variables in the domains of sociodemographics, SLE specific, comorbidities, baseline haematology/biochemistry/immunology and treatment data were collected by ≥75% respondents including the 1997 American College of Rheumatology (ACR) Classification Criteria (83%), SLE Disease Activity Index-2000 (82%), current treatment (100%), drug name, dose, frequency and start date (75-100%) and complement C3/4 (94%). A range of other items was collected by 50-<75% of respondents including SLICC 2012 Criteria (67%), SLICC/ACR Damage Index (68%) and Short Form Health Survey-36 (53%). Less than 50% of respondents collect certain items including European Alliance of Associations for Rheumatology/ACR 2019 criteria (33%), British Isles Lupus Assessment Group scores (12%) and pneumococcal vaccine status (39%).

Conclusions: The frequency with which an initial set of variables is collected in SLE cohorts globally was identified and can form the basis from which to develop a core minimum dataset for SLE. Further refinement and common definitions will be needed to finalise a minimal core dataset suitable for widespread use.

Keywords: Clinical Trial; Lupus Erythematosus, Systemic; Lupus Nephritis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: SM was a speaker for UCB and has received support for meetings from Novartis, Eli Lily and UCB. AEC holds The Arthritis Society Chair in Rheumatic Diseases. INB has received grant support from Genzyme/Sanofi, GlaxoSmithKline, Roche and UCB; consulting fees from AstraZeneca, Eli Lilly, GlaxoSmithKline, Merck Serono and UCB and was a speaker for AstraZeneca, GlaxoSmithKline and UCB.

References

1. Yap DYH, Chan TM. Lupus Nephritis in Asia: Clinical Features and Management. Kidney Dis . 2015;1:100–9. doi: 10.1159/000430458. - DOI - PMC - PubMed
1. Lockshin MD, Barbhaiya M, Izmirly P, et al. SLE: reconciling heterogeneity. Lupus Sci Med. 2019;6:e000280. doi: 10.1136/lupus-2018-000280. - DOI - PMC - PubMed
1. Williamson PR, Altman DG, Bagley H, et al. The COMET Handbook: version 1.0. Trials. 2017;18:280. doi: 10.1186/s13063-017-1978-4. - DOI - PMC - PubMed
1. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725. doi: 10.1002/art.1780400928. - DOI - PubMed
1. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288–91. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- HighWire
- PubMed Central
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Towards a minimal core dataset for systemic lupus erythematosus studies

Affiliations

Towards a minimal core dataset for systemic lupus erythematosus studies

Authors

Affiliations

Abstract

Conflict of interest statement

References

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous